Category: Miscellaneous

    By Donald Zuhn — A paper published in the latest issue of the policy journal Health Affairs disputes the widely held notion that the United States has eclipsed Europe in terms of pharmaceutical research productivity.  In the article, entitled "Global Drug Discovery: Europe Is Ahead," Dr. Donald Light, a professor of social medicine in…

    By Donald Zuhn — Recently, we were contacted by Matthew Smith (at right), an associate in Foley & Lardner's Washington, DC office and an adjunct professor at the George Washington University Law School, who wanted to let us know about a treatise on inter partes reexamination that he had just completed.  Prof. Smith also…

The authors and contributors of Patent Docs wish their readers a Happy Holidays.  Publication of Patent Docs will resume on December 26th.

    By Michael H. Baniak & Suresh B. Pillai — I.  INTRODUCTION Patent owners enjoy most of the same benefits, including the right to exclude and the freedom to contract, as the owners of other types of personal property.  Balanced with these ordinary rights, however, is Congress's concern that the property rights of the patent…

Due to some problems associated with the renewal of our alternate domain names, the Patent Docs weblog can no longer be reached via the patentdocs.net or patentdocs.us web addresses.  We recommend that you replace bookmarks to either of the above addresses with the following address: http://www.patentdocs.typepad.com/

Patent Docs provides two reviews for the price of one as Kevin Noonan and Donald Zuhn each discuss the second edition of Martin Voet’s book "The Generic Challenge: Understanding Patents, FDA & Pharmaceutical Life-Cycle Management."     By Kevin Noonan — Martin A. Voet, Senior Vice President and Chief Intellectual Property Counsel at Allergan, Inc.,…

    By Donald Zuhn — Managing Intellectual Property has released its sixth annual list of the most influential people in intellectual property (see "Politics, power and passion — this year’s MIP 50").  The MIP 50 appears in the magazine’s July/August issue, and can also be found on the magazine’s website (access to the online…

    By Donald Zuhn — Rolf Claessen, a patent attorney with Kreisler Selting Werner in Cologne, Germany, recently contacted Patent Docs to let us know about a new tool he is offering on his useful IP portal, IP Newsflash.  The new tool, Free Patent PDF Download, allows patent practitioners to download patents and published…

Patent Docs Readers: Normally, we do not address the online tools that make it possible to bring Patent Docs to a browser, RSS reader, or e-mail client near you.  However, because we have become aware of some issues regarding the delivery (or lack thereof) of our e-mail newsletter, we would like to make an exception…

    By Kevin E. Noonan — In 2004, Purdue Pharma L.P. and its related companies were found to have obtained patents (U.S. Patent Nos. 5,656,295; 5,508,042; and 5,549,912) for their OxyContin® opioid pain relief formulations through inequitable conduct.  The basis for this determination was that Purdue had maintained before the Patent Office that its…